India is preparing for a broader overhaul of health insurance as rapidly rising medical costs put pressure on households, insurers and hospitals. The proposed reforms are expected to focus on standard treatment prices, clearer coverage rules and faster claims processing, according to people familiar with the discussions. The central objective is not simply to expand insurance coverage, but to make insured healthcare more predictable and affordable in a market where treatment costs are rising much faster than general inflation.

Medical inflation in India has remained around 12 percent to 14 percent annually in recent estimates, significantly above overall consumer inflation. That pressure eventually reaches insurance premiums because insurers must account for higher hospital bills when pricing policies and renewing coverage. Industry analysis has also pointed to persistent pressure from claims costs, with health insurance remaining one of the fastest-growing segments of the non-life insurance market.

The reform discussions therefore reflect a deeper problem in India’s healthcare system. Insurance can protect households from large medical bills, but it cannot by itself control the prices charged by hospitals, the variation in treatment costs or the administrative disputes that arise when insurers and hospitals disagree over claims. Unless those underlying problems are addressed, expanding insurance coverage could simply expose more households to rising premiums and complicated claim settlements.

Standard treatment prices could change the insurance market

One of the most important proposals under discussion is the creation of benchmark treatment rates agreed between insurers and hospitals. The intention is to establish clearer reference prices for common procedures and reduce disputes over how much insurers should reimburse healthcare providers.

At present, hospital charges can vary considerably depending on location, provider, room category and treatment. That makes it difficult for consumers to know whether the amount charged for a procedure is reasonable before treatment begins. It also complicates the work of insurers because they must determine whether a hospital’s bill reflects an appropriate cost for the treatment provided.

A standardised pricing framework could improve transparency if it is based on reliable data and regularly updated. It could also make it harder for inflated or inconsistent billing practices to continue unnoticed. But setting benchmarks will not automatically reduce healthcare costs. Hospitals have different operating expenses, staffing structures and levels of specialised care, meaning that a single national price for every provider could create problems of its own.

The challenge will therefore be to establish reference rates that control excessive pricing without discouraging hospitals from investing in equipment, specialist services and medical infrastructure.

The claims system is another major source of friction

The proposed expansion of the National Health Claims Exchange could address a different part of the problem. The platform has been developed to standardise the exchange of health insurance claims information between hospitals, insurers and other participants in the system. Government updates show that the platform is already being adopted by insurers and hospitals, with the aim of making claims processing more interoperable, verifiable and efficient.

The importance of such a system lies in reducing the fragmentation of health insurance administration. Hospitals and insurers often operate with different data formats and documentation requirements, creating delays in verification and settlement. A common digital system could reduce manual processing, improve access to billing information and make it easier to identify inconsistencies in claims.

That could benefit consumers directly. Faster processing would reduce uncertainty for patients waiting for cashless treatment approvals or reimbursement. Better data sharing could also help insurers identify unusual billing patterns and investigate potentially fraudulent claims more efficiently.

But technology cannot resolve every dispute. A digital claims platform can make information easier to exchange, but it cannot independently determine whether a medical procedure was clinically necessary or whether a hospital’s price is justified. Those decisions still require agreed standards, professional judgement and regulatory oversight.

Fraud is adding to the cost burden

Another reason policymakers are examining the claims system is concern over unnecessary or fraudulent claims. Industry estimates cited in the reform discussions suggest that 10 percent to 15 percent of health claims could be unwarranted or fraudulent.

Even if the precise proportion requires further verification, the broader problem is well established: weaknesses in claims administration can increase costs for insurers and ultimately affect premiums paid by policyholders. Suspicious billing, unnecessary procedures, inflated charges and inconsistent documentation can all make it more difficult to distinguish legitimate medical expenditure from avoidable costs.

A stronger claims exchange could help by creating a common digital trail across the insurance system. That would make it easier to compare treatment, billing and patient information and identify unusual patterns.

However, stricter fraud controls must also avoid creating a new problem. If insurers become excessively cautious and reject legitimate claims because of incomplete documentation or automated risk signals, policyholders could face more disputes rather than fewer. The success of the reform will therefore depend on balancing fraud detection with fair and transparent claim settlement.

A common insurance product could simplify choices

The proposed common health insurance product is intended to address another weakness in the market: the complexity of comparing policies. More than 40 insurers operate in India’s health insurance market, offering products with different exclusions, limits, benefits and treatment conditions.

Competition can encourage insurers to innovate, but excessive variation can make it difficult for consumers to understand what they are actually purchasing. Two policies may advertise similar levels of coverage while differing substantially in exclusions, room-rent limits, waiting periods or admissible treatments.

A mandatory standard product offered alongside existing policies could create a common baseline. Consumers would have at least one product whose core coverage and pricing structure could be compared across insurers.

That would not eliminate competition. Insurers could continue offering more specialised products, additional benefits and different levels of service. The standard product would instead provide consumers with a common reference point.

The approach could also reduce the tendency to switch policies simply because another insurer appears cheaper or offers a different interpretation of coverage. Better standardisation could shift competition toward service quality, claims settlement and actual value rather than increasingly complicated product structures.

Controlling hospital prices is harder than controlling insurance

The most difficult part of the reform agenda may be addressing healthcare prices themselves. Insurance companies can negotiate with hospitals, but hospitals ultimately determine many of the costs that enter the insurance system.

Private healthcare is substantially more expensive than public treatment in many parts of India, according to parliamentary analysis cited in the current debate. That difference is important because private hospitals account for a large share of insured healthcare consumption, particularly among middle-class households seeking faster access to specialised treatment.

Standardised tariffs could therefore have a meaningful effect on insurance costs if they are widely accepted. But hospitals may resist benchmarks that they believe do not reflect their actual costs. Smaller hospitals could face different financial pressures from large corporate institutions, while specialist centres may have higher costs because of advanced equipment and highly trained staff.

This means the government will need to avoid treating price standardisation as a simple price cap. A sustainable system would need reliable cost data, regular revisions and mechanisms to account for differences in services and quality.

More insurance will not help if coverage remains unaffordable

India’s insurance penetration remains below the global average, with insurance spending accounting for less than 4 percent of gross domestic product compared with more than 7 percent globally. The government has been trying to expand the sector through regulatory changes, including greater foreign investment and reforms to distribution.

But higher coverage cannot be achieved simply by encouraging people to buy policies. Rising premiums can discourage households from maintaining coverage, particularly when medical inflation is significantly higher than general inflation.

Health insurance premiums can rise because of several factors, including medical costs, age, claims experience, product design and insurer pricing decisions. Medical inflation is therefore an important pressure, but it is not the only one.

This makes cost control essential to the government’s broader insurance-expansion strategy. If healthcare becomes progressively more expensive, insurers will either have to raise premiums, reduce the attractiveness of products or accept greater losses. None of those outcomes is likely to encourage wider long-term insurance adoption.

Reform must address the entire healthcare chain

The proposed reforms are significant because they attempt to address several parts of the same problem at once: hospital pricing, claims administration, fraud, policy complexity and limited transparency. The National Health Claims Exchange already provides a technological foundation for improving claims processing, while standardised products and treatment benchmarks could address some of the commercial disputes that technology alone cannot solve.

The harder question is implementation. India has a highly diverse healthcare system, with major differences between public and private providers and between metropolitan hospitals and smaller facilities. A national framework will have to accommodate those differences without allowing them to become loopholes that undermine standardisation.

The reforms could eventually make health insurance easier to understand and claims easier to process, but they will not automatically stop medical inflation. The more fundamental test will be whether insurers, hospitals and regulators can establish credible treatment prices, improve billing transparency and use better claims data without compromising patient access.

For a country seeking to increase insurance coverage, controlling the cost of insured healthcare is becoming as important as selling more policies. The emerging reform agenda recognises that problem. Its success will depend on whether India can turn greater transparency and standardisation into actual reductions in unnecessary costs rather than simply adding another layer of regulation to an already complex healthcare system.

(Adapted from BRecorder.com)